Oxygenta Pharmaceutical Ltd Share Price

AGM Date: 31 Dec 2021

AGM:31.12.2021 This is to inform you that the Board of Directors of the Company at its meeting held on 06th December, 2021 fixed the Day, Date, Time and Venue for the 28th Annual General Meeting of the Company and also approved the Notice of 28th Annual General Meeting of the members of the Company is scheduled to be held on Friday, the 31st day of December, 2021 at 03:00 P.M. at the Registered Office of the Company Situated at Survey No. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy District, Telangana State - 502 291. (As per BSE Announcement Dated on 6/12/2021) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the proceedings of 28th Annual General Meeting held on Friday 31st December, 2021 at 03.00 PM at Survey No. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy Dist. Telangana State. (As per BSE Announcement Dated on 31/12/2021) With reference to the above mentioned subject, please find enclosed the Scrutinizer Reports submitted by the Scrutinizer for voting results of 28th AGM held on Friday, the 31st December, 2021 of the company. This is for your information and records. Thanking you, With reference to the above mentioned subject, please find enclosed the details of Voting results (by remote e-voting and voting by poll) of 28th Annual General Meeting of the Company held on Friday, the 31 December, 2021 pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As per BSE Announcement Dated on 03/01/2022) SS Organics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 04.01.2021)

AGM Date: 26 Sep 2022

AGM 26/09/2022 The 29th (Twenty-Nineth) Annual General Meeting ('AGM'') of the Company will be held on Monday, 26th September, 2022 at 03:00 P.M. through Video Conferencing/ Other Audio Visual Means. Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are herewith submitting the Annual Report of the Company for the FY 2021-22 along with Notice of AGM, which is being sent to the members through electronic mode. The Annual Report along with the Notice is also uploaded on the Company's website http://oxygentapharma.com/annual_reports.html This is for your information and records. (As Per BSE Announcement dated on 05.09.2022) In due compliance with the provisions of the Companies Act, 2013 read with Rules made thereunder Oxygenta Pharmaceutical Limited ('the Company') circulated a Notice dated 03rd September 2022 ('AGM Notice') to all its shareholders for convening the AGM as mentioned above. Certain inadvertent errors have been noticed in the Explanatory Statement annexed with the AGM Notice in respect of the special resolution (Item. no. 7,8 & 9 of the AGM Notice). Accordingly, vide this Addendum, we wish to inform our shareholders the explanatory statement part of the AGM Notice shall be read as under. Other contents of the AGM Notice remain unchanged. This addendum shall form an integral part of AGM Notice and shall also be available at Corporate Announcement Section of the Company's website http://oxygentapharma.com/, on the website of and on the website of the Stock Exchanges i.e. BSE Limited at www.bseindia.com. This is for your information and records. (As Per BSE Announcement Dated on 21.09.2022) With reference to the subject cited, we are pleased to inform you that the 29thAnnual General Meeting (AGM) of the Shareholders of the Company was held on 26th day of September, 2022, at 03.00 P.M., through Video Conferencing/ Other Audio-Visual Means (VC/OAVM). Please find the attached Proceedings of the 29th Annual General Meeting of the Shareholders of the Company. Please take the same on record. (As Per BSE Announcement dated on 27.09.2022) With reference to the subject cited, we are pleased to inform you that the 29th Annual General Meeting (AGM) of the Shareholders of the Company was held on 29th day of September, 2022, at 03.00 P.M., through Video Conferencing! Other Audio-Visual Means (VC/OAVM). Please find the attached Voting Results of the 29th Annual General Meeting of the shareholders of the Company along with the Scrutinizer''s Report. (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 30 Sep 2023

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of directors of the Company, at their meeting held on Monday, 04th September 2023 inter alia, transacted the following items of business: Voting results and report of scrutinizer of 30th Annual General meeting. (As Per BSE Announcement Dated on 01.10.2023)

AGM Date: 30 Sep 2024

31st Annual general meeting Notice paper ad attached herewith Outcome of 31st AGM of the company held on 30th September 2024. (As per BSE Announcement Dated on 30/09/2024) Voting result along with Scrutinizer report for 31st AGM. (As per BSE Announcement Dated on 03/10/2024)

AGM Date: 19 Sep 2025

Outcome of Board meeting held on 25.08.2025 Book Closure Intimation for the Annual General Meeting for the Financial Year 2024-25 scheduled to be held on 19.09.2025. (As per BSE Announcement Dated on 28/08/2025) Submission of Notice of 32nd Annual General meeting for the Finanical Year 2024-25. (As per BSE Announcement dated on: 28.08.2025) Outcome of the 32nd Annual General Meeting of the Company. Secrutinzers Report and Voting Results for AGM held on 19.09.2025 (As per BSE Announcement dated on: 19.09.2025)

EGM Date: 23 Mar 2023

Pursuant to Regulation 30 read with Part A of Schedule III, of the Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Board Meeting held on 27th February, 2023, inter-alia considered and approved: 1. Increase in Authorized Share Capital of the company 2. Issue of 73,95,000 equity shares of the Company on preferential basis for consideration of Cash 3. Issue of 1,28,37,200 share warrants convertible into equal no. of equity shares of the Company on preferential basis: 4. Issue of up to 5,50,000 equity shares by conversion of Loan 5. Finalisation of date, day, Time, Venue, Cut-off date and Notice for the Extra-Ordinary General Meeting of the Company 6. Appointment of scrutinizer for the purpose of e-voting Thank you The Extra-Ordinary General Meeting of the Company ('EGM') is scheduled to be held on Thursday, March 23, 2023 at 03.00 p.m. (IST) at Registered Office Situated at Survey no. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy District, Telangana State - 502291 pursuant to the general circulars issued by the Ministry of Corporate affairs and by the Securities and Exchange Board of India ('SEBI'). Pursuant to the provisions of Regulation 30 and other applicable provisions of the SEBI (LODR) Regulations, 2015, please find enclosed herewith the Notice convening the EGM together with the explanatory statement. The aforesaid Notice is also uploaded on the Company's website i.e., www.oxygentapharma.com. (As Per BSE Announcement dated on 01.03.2023) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the proceedings of Extra Ordinary General Meeting held on Thursday 23rd March, 2023 at 03.00 PM at Survey No. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy Dist. Telangana State. This is for your information and records. Thanking you, (As Per BSE Announcement dated on 23.03.2023) With reference to the subject cited, we are pleased to inform you that the Extra Ordinary General Meeting (EGM) of the Shareholders of the Company was held on 23rd day of March, 2023, at 03.00 P.M., at registered office of the Company situated at Survey No. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy Dist. Telangana State - 502 291. Please find the attached Voting Results of the Extra Ordinary General Meeting of the shareholders of the Company along with the Scrutinizer''s Report. Please take the same on record. Thanking you, (As Per BSE Announcement Dated on 24.03.2023)

EGM Date: 09 May 2024

Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Board Meeting held today, April 08, 2024, inter-alia, considered and approved the following: We would like to inform you that the Extra-Ordinary General Meeting (EGM) of the Company is scheduled to be held on Thursday, May 09, 2024. In this regard, we hereby submit the notice of the EGM. (As Per BSE Announcement Dated on 13/04/2024) EGM 09/05/2024 (As Per BSE Bulletin Dated on 15.04.2024) Pursuant to the regulation 30 of SEBI (LODR) Regulations 2015, We hare by submit the proceedings of the EGM. (As Per BSE Announcement Dated on 09/05/2024) We hereby submit the consolidated report of Scrutinizer We hereby submit the Voting results of the EGM held on May 09,2024. (As per BSE Announcement Dated on 10/05/2024)